To ensure that toxicity of GrB/VEGF121 is both targeted and specific, we evaluated a panel of endothelial and tumor cells lines with varying levels of VEGFR-1 and VEGFR-2 on their cell surface. This evidence concerns the gene KDR and neoplasm.